Bautista, Crizel M.
HRN: 23-09-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2024
CEFUROXIME 750MG (VIAL)
06/17/2024
06/24/2024
IV
650mg
Q 8 Hours
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes